J Korean Vasc Surg Soc.  1998 Apr;14(1):61-65.

Iliac Artery Stenosis and Occlusion: Treatment of Metallic Stent

Affiliations
  • 1Department of Radiology, Hallym University Medical College, Korea.
  • 2Department of Radiology, Seoul National University Medical College, Seoul, Korea.

Abstract

INTRODUCTION: Percutaneous transluminal angioplasty(PTA) has been widely accepted for the treatment of arterial stenosis. However, acute thrombosis, localized dissection or recoiling may occur as complication, resulting in acute occlusion. Restenosis is also a problem in long term follow up. Recent advance of metallic stent is considered as a good relief for the problems of PTA. PURPOSE: We analyzed 11 patients with metallic stent in the treatment of the iliac artery stenosis. METHOD: Subjects were male patients aged from 53 to 79 years old. All were suffered from claudication of lower extremities, pain and discolorization and diagnosed as atherosclerosis. Pelvic arteriography was performed to localize the stenotic lesion. Through the ipsilateral arterial puncture, metallic stent was inserted after PTA. The metallic stents were Wall stent in 7, Hanaro stent in 2, Palmaz stent 2 and Memotherm stent in 2 lesions. RESULT: The indications for metallic stent were long segment patients, in all cases, the stent was successfully inserted. The pressure gradient measured improved significantly after procedure. For the 3 to 24 months follow up, symptoms has not relapsed clinically.
CONCLUSION
On the basis of our priliminary experience, Metallic stent is safe and effective for the treatment of iliac arterial stenosis in conjunction with PTA and surgery.

Keyword

Iliac artery; Stenosis and occlusion; Metallic stent

MeSH Terms

Aged
Angiography
Atherosclerosis
Constriction, Pathologic*
Follow-Up Studies
Humans
Iliac Artery*
Lower Extremity
Male
Punctures
Stents*
Thrombosis
Full Text Links
  • JKVSS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr